Top

Published in:

01-04-2019 | Concise Research Reports

A Cross-sectional Survey Using Clinical Vignettes to Examine Overdose Risk Assessment and Willingness to Prescribe Naloxone

Authors: J. Deanna Wilson, MD, MPH, Justin Berk, MD, MPH, MBA, Pamela Matson, PhD, MPH, Natalie Spicyn, MD, MHS, Anika Alvanzo, MD, MHS, Hoover Adger, MD, MPH, MBA, Leonard Feldman, MD

Published in: Journal of General Internal Medicine | Issue 4/2019

Excerpt

The number of opioid-related overdose deaths has increased concurrently with rising rates of opioid use nationally.¹ Clinical encounters offer an opportunity to provide high-risk patients with targeted interventions,² yet clinicians routinely miss the opportunity to deliver risk reduction counseling and naloxone to appropriate patients³ due, in part, to knowledge gaps.^{4, 5} …

Volkow ND and McLellan AT. Opioid abuse in chronic-pain--misconceptions and mitigation strategies. NEJM. 2016;374:1253–63.CrossRefPubMed

Coffin PO, Behar E, Rowe C, et al. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016;165(4):245. doi:https://doi.org/10.7326/M15-2771.CrossRefPubMedPubMedCentral

Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med. 2011;26(9):958–964. doi:https://doi.org/10.1007/s11606-011-1648-2.CrossRefPubMedPubMedCentral

Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015;30(12):1837–1844. doi:https://doi.org/10.1007/s11606-015-3394-3.CrossRefPubMedPubMedCentral

Wilson JD, Spicyn N, Matson P, Alvanzo A, Feldman L. Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings. Subst Abus. 2016;37(3):480–487. doi:https://doi.org/10.1080/08897077.2016.1142921.CrossRefPubMedPubMedCentral

Haug NA, Bielenberg J, Linder SH, Lembke A. Assessment of provider attitudes toward #naloxone on Twitter. Subst Abus. 2016;37(1):35–41. doi:https://doi.org/10.1080/08897077.2015.1129390.CrossRefPubMed

Title: A Cross-sectional Survey Using Clinical Vignettes to Examine Overdose Risk Assessment and Willingness to Prescribe Naloxone
Authors: J. Deanna Wilson, MD, MPH
Justin Berk, MD, MPH, MBA
Pamela Matson, PhD, MPH
Natalie Spicyn, MD, MHS
Anika Alvanzo, MD, MHS
Hoover Adger, MD, MPH, MBA
Leonard Feldman, MD
Publication date: 01-04-2019
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue 4/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-018-4733-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2019

Practicing Medicine with Colleagues: Pitfalls from Social Psychology Science

Association of Health Literacy and Numeracy with Interest in Research Participation

CMS Billing Guidelines and Student Documentation: a New Era or New Burden?

Trends, Management Patterns, and Predictors of Leaving Against Medical Advice among Patients with Documented Noncompliance Admitted for Acute Myocardial Infarction

Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions

Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials